{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:12:10Z","timestamp":1781626330027,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001027","name":"CH Foundation","doi-asserted-by":"publisher","award":["241865"],"award-info":[{"award-number":["241865"]}],"id":[{"id":"10.13039\/100001027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Tech University Health Sciences Center School of Medicine","award":["121035"],"award-info":[{"award-number":["121035"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.neuropharm.2016.11.018","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T04:31:12Z","timestamp":1480048272000},"page":"168-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence"],"prefix":"10.1016","volume":"114","author":[{"given":"Jos\u00e9e","family":"Guindon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.11.018_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pneurobio.2008.09.018","article-title":"Towards a theory of chronic pain","volume":"87","author":"Apkarian","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bph.13337","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model","volume":"173","author":"Adamson Barnes","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1152\/jn.00284.2013","article-title":"Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans","volume":"110","author":"Becerra","year":"2013","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib5","series-title":"Sensation and Perception in the History of Experimental Psychology","author":"Boring","year":"1942"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib6","series-title":"Lectures on the History of Physiology during 16th, 17th, and 18th Centuries","article-title":"L'homme translated by M. Foster","author":"Descartes","year":"1664"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15360288.2014.941130","article-title":"The pharmacokinetics, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study","volume":"28","author":"Eisenberg","year":"2014","journal-title":"J.\u00a0Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/sj.npp.1301051","article-title":"Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents","volume":"31","author":"Elman","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib10","first-page":"715","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2165\/00003495-200767150-00002","article-title":"Recent advances in the pharmacological management of pain","volume":"67","author":"Guindon","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","volume":"67","author":"Guindon","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pbb.2014.07.008","article-title":"Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models","volume":"124","author":"Grim","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J.\u00a0Pain Symptom Manag."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(06)68700-X","article-title":"Persistent postsurgical pain: risk factors and prevention","volume":"367","author":"Kehlet","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurocircuitry of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrn2333","article-title":"A\u00a0common neurobiology for pain and pleasure","volume":"9","author":"Leknes","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib19","series-title":"Pain and Suffering","author":"Livingstone","year":"1998"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib20","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in\u00a0vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","article-title":"Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials","volume":"10","author":"Lynch","year":"2015","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"issue":"Suppl.\u00a06","key":"10.1016\/j.neuropharm.2016.11.018_bib22","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0304-3959(99)00145-1","article-title":"From the gate to the neuromatrix","author":"Melzack","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.150.3699.971","article-title":"Pain mechanisms: a new theory","volume":"150","author":"Melzack","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib24","first-page":"769","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.tins.2015.09.003","article-title":"Brain circuits encoding reward from pain relief","volume":"38","author":"Navratilova","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-662-46450-2_13","article-title":"Amygdala pain mechanisms","volume":"227","author":"Neugebauer","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib29","doi-asserted-by":"crossref","first-page":"10789","DOI":"10.1523\/JNEUROSCI.2577-06.2006","article-title":"Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity","volume":"26","author":"Scott","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib30","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1523\/JNEUROSCI.5280-10.2011","article-title":"Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function","volume":"31","author":"Seminowicz","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-642-28720-6_170","article-title":"Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points","volume":"13","author":"Soderpalm","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.018_bib32","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/sj.npp.1300754","volume":"30","author":"Solinas","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib34","first-page":"1113","article-title":"How neuroimaging studies have challenged us to rethink: is chronic pain a disease?","volume":"10","author":"Tracey","year":"2009","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib35","first-page":"T50","article-title":"Toward a mechanism-based approach to pain diagnosis","volume":"17","author":"Vardeh","year":"2016","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2016.11.018_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2016.11.015","article-title":"The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine induced antinociception, and attenuated heroin seeking behavior in mice","volume":"114","author":"Wilkerson","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T19:43:38Z","timestamp":1568576618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816305226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"alternative-id":["S0028390816305226"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}